Related Experiment Video
Updated: Aug 8, 2026
Study of Dendritic Cell Development by Short Hairpin RNA-Mediated Gene Knockdown in a Hematopoietic Stem and Progenitor Cell Line In vitro
Published on: March 7, 2022
Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis
1Department of Pathology and Laboratory Medicine, University Medical Center Groningen and University of Groningen, The Netherlands.
Insights
Langerhans cell histiocytosis (LCH) involves clonal cell proliferation. This study identified novel genes, including MMP12, highly expressed in LCH, potentially driving disease progression.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- Langerhans cell histiocytosis (LCH) is a rare neoplastic disorder characterized by clonal proliferation of cells with a Langerhans cell (LC) phenotype.
- The underlying pathogenesis of LCH remains incompletely understood.
- Identifying specific molecular markers is crucial for understanding LCH development and progression.
Purpose of the Study:
- To identify novel genes expressed in LCs and investigate their role in LCH pathogenesis.
- To explore the expression patterns of identified genes in LCH patient samples.
- To elucidate potential molecular mechanisms contributing to LCH progression.
Main Methods:
- Serial analysis of gene expression (SAGE) was performed on LCs derived from CD34+ progenitor cells.
- Quantitative RT-PCR was used to validate gene expression levels in LCH cases.
- Immunohistochemistry was employed to confirm protein expression.
Main Results:
- Several known LC-associated genes (CD1a, LYZ, CD207) were confirmed.
- Novel genes, including GSN, MMP12, CCL17, and CCL22, showed high expression in LCs.
- FSCN1 and GSN were highly expressed in all analyzed LCH cases; MMP12 expression correlated with multi-system LCH, a severe form of the disease.
Conclusions:
- This study reveals new insights into the molecular pathology of LCH.
- The identified genes, particularly MMP12, may play significant roles in LCH progression.
- These findings provide novel targets for future research into LCH treatment and management.
Abstract:
Langerhans cell histiocytosis (LCH) is a neoplastic disorder that results in clonal proliferation of cells with a Langerhans cell (LC) phenotype. The pathogenesis of LCH is still poorly understood. In the present study, serial analysis of gene expression (SAGE) was applied to LCs generated from umbilical cord blood CD34+ progenitor cells to identify LC-specific genes and the expression of these genes in LCH was investigated. Besides the expression of several genes known to be highly expressed in LCs and LCH such as CD1a, LYZ, and CD207, high expression of genes not previously reported to be expressed in LCs, such as GSN, MMP12, CCL17, and CCL22, was also identified. Further analysis of these genes by quantitative RT-PCR revealed high expression of FSCN1 and GSN in all 12 LCH cases analysed; of CD207, MMP12, CCL22, and CD1a in the majority of these cases; and CCL17 in three of the 12 cases. Immunohistochemistry confirmed protein expression in the majority of cases. The expression of MMP12 was most abundant in multi-system LCH, which is the LCH type with the worst prognosis. This suggests that expression of MMP12 may play a role in the progression of LCH. These data reveal new insight into the pathology of LCH and provide new starting points for further investigation of this clonal proliferative disorder.